Chronic myeloid leukemia, though a type of leukemia, is not terrifying because there are targeted drugs available for it, namely tyrosine kinase inhibitors. These inhibitors have been developed into first, second, and third-generation products. Most cases of chronic granulocytic leukemia can achieve clinical remission after oral administration of tyrosine kinase inhibitors. Some patients might experience a blast crisis, acceleration phase, or relapse during treatment, but they can switch to higher-grade tyrosine kinase inhibitors or undergo allogeneic hematopoietic stem cell transplantation. Thus, chronic myeloid leukemia is no longer considered a frightening disease. (Please use medication under the guidance of a doctor.)